BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36175317)

  • 21. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
    Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
    Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Li TC; Wang Y; Xiao CT; Li MZ; Liu XP; Huang WT; Li LY; Li K; Di JM; Wen XQ; Gao X
    Asian J Androl; 2022; 24(1):97-101. PubMed ID: 34213490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases.
    Maccio L; Barresi V; Domati F; Martorana E; Cesinaro AM; Migaldi M; Iachetta F; Ieni A; Bonetti LR
    Intern Emerg Med; 2016 Apr; 11(3):399-404. PubMed ID: 26875178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performed.
    Ramírez-Backhaus M; Mir Maresma MC; Mascarós JM; Bertolo R; Hernández J; Gómez Ferrer A; Casanova-Ramón Borja J; Domínguez Escrig JL; Collado-Serra A; Calatrava Fons A; Rubio-Briones J
    Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):480-487. PubMed ID: 31174878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy.
    Claps F; Ramírez-Backhaus M; Mir Maresma MC; Gómez-Ferrer Á; Mascarós JM; Marenco J; Collado Serra A; Casanova Ramón-Borja J; Calatrava Fons A; Trombetta C; Rubio-Briones J
    Int J Urol; 2021 May; 28(5):566-572. PubMed ID: 33675069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative Fluorescence Imaging for Detection of Sentinel Lymph Nodes and Lymphatic Vessels during Open Prostatectomy using Indocyanine Green.
    Yuen K; Miura T; Sakai I; Kiyosue A; Yamashita M
    J Urol; 2015 Aug; 194(2):371-7. PubMed ID: 25584996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific Membrane Antigen-radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases.
    Lunger L; Steinhelfer L; Korn P; Eiber M; Maurer T; Büchler J; Horn T; Gschwend JE; Heck MM
    Eur Urol Oncol; 2023 Feb; 6(1):95-98. PubMed ID: 36604297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.
    Dell'Oglio P; Abdollah F; Suardi N; Gallina A; Cucchiara V; Vizziello D; Zaffuto E; Cantiello F; Damiano R; Shariat S; Montorsi F; Briganti A
    J Endourol; 2014 Apr; 28(4):416-23. PubMed ID: 24188052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution.
    Tomisaki I; Ikuta H; Higashijima K; Onishi R; Minato A; Fujimoto N
    Cancer Invest; 2019; 37(10):524-530. PubMed ID: 31597501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.
    Bianchi L; Gandaglia G; Fossati N; Suardi N; Moschini M; Cucchiara V; Bianchi M; Damiano R; Schiavina R; Shariat SF; Montorsi F; Briganti A
    Urologia; 2017 Feb; 84(1):9-19. PubMed ID: 26689534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
    Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
    Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
    Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
    Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer.
    Colicchia M; Sharma V; Abdollah F; Briganti A; Jeffrey Karnes R
    Curr Urol Rep; 2017 Jul; 18(7):51. PubMed ID: 28589397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer.
    Mazzone E; Dell'Oglio P; Grivas N; Wit E; Donswijk M; Briganti A; Leeuwen FV; Poel HV
    J Nucl Med; 2021 Oct; 62(10):1363-1371. PubMed ID: 33547208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille.
    Maderthaner L; Furrer MA; Studer UE; Burkhard FC; Thalmann GN; Nguyen DP
    BJU Int; 2018 May; 121(5):725-731. PubMed ID: 28834085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.